Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-01 · accession 0001493152-25-020753 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-04 | 2025-11-01 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $0.75 | +58.6K | 32.0K | New | +$44.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2025-11-01 | A | A | 26,619 | $0.75 | 26,619 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer (F3) These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on February 15, 2026. |
| 2 | Common | American Depositary Shares representing Ordinary Shares | 2025-11-01 | A | A | 32,000 | $0.75 | 32,000 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer (F2) These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026. |